PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1822291
PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1822291
The global lateral flow assay (LFA) components market is projected to reach USD 486.2 million by 2030 from USD 392.4 million in 2025, at a CAGR of 4.4% during the forecast period.
Scope of the Report | |
---|---|
Years Considered for the Study | 2024-2030 |
Base Year | 2024 |
Forecast Period | 2025-2030 |
Units Considered | Value (USD billion) |
Segments | Product, Application, Technique, Sample Type, and End User |
Regions covered | North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries |
In recent years, the lateral flow assay components market has gained significant momentum, driven by the increasing prevalence of infectious diseases, rising demand for point-of-care testing, and greater adoption of home-based diagnostics. Ongoing improvements in membranes, pads, and related materials have improved test accuracy and reduced turnaround times, expanding their use in clinical, veterinary, food safety, and drug development settings. Along with established companies, a growing number of small and specialized manufacturers are leading innovation in material design and production methods, offering unique solutions that meet diverse end-user needs and requirements.
"The sandwich assays segment of the lateral flow assay components market, by technique, is expected to hold the largest position during the forecast period."
The lateral flow assay components market is divided into sandwich assays, competitive assays, and multiplex detection assays. Among these, sandwich assays held the largest market share in 2024, due to their higher sensitivity, specificity, and suitability for detecting larger analytes like bacterial pathogens, viral antigens, and key biomarkers. In this method, the analyte is "sandwiched" between two highly specific antibodies, creating a signal that directly correlates with analyte concentration, ensuring reliable and quantitative results. The dominance of sandwich assays is further supported by their use in some of the most common diagnostic tests, including pregnancy testing (hCG), infectious disease testing (HIV, hepatitis B, H. pylori), and cardiac marker detection (troponin, CK-MB, myoglobin). Their ability to consistently produce strong control line signals, regardless of analyte levels, improves test reliability-a vital aspect for clinical and home-based diagnostics. As healthcare providers increasingly adopt point-of-care solutions, the demand for membranes, conjugate pads, and nanoparticles tailored to sandwich assay formats continues to grow. In contrast, competitive assays-more suitable for small molecules with a single antigenic determinant-remain important in areas like drug-of-abuse testing and certain food safety applications. Meanwhile, multiplex detection assays are gaining popularity for their capacity to analyze multiple targets simultaneously. Nevertheless, it is the extensive clinical applications and established diagnostic accuracy of sandwich assays that primarily drive the consumption of components worldwide market.
"The medical device manufacturing companies accounted for the largest market share in the lateral flow assay components market, by end user."
The lateral flow assay components market, by end user, is divided into medical device manufacturing companies and medical device contract manufacturing companies. Among these, medical device manufacturing companies led the market in 2024, holding the largest share because of their extensive role in designing, engineering, and producing a wide range of diagnostic devices. These companies, including Abbott (US), Hoffmann-La Roche (Switzerland), Danaher Corporation (US), Siemens Healthineers (Germany), Bio-Rad Laboratories (US), Thermo Fisher Scientific (US), PerkinElmer (US), Hologic (US), and Merck KGaA (Germany), are the main consumers of membranes, pads, conjugates, and housing materials. The increasing prevalence of infectious diseases, the growing elderly population, and the rising adoption of home-based and point-of-care diagnostics have driven the integration of LFA components into diagnostic product portfolios. This has made medical device manufacturers the primary demand drivers in the component market. Meanwhile, medical device contract manufacturing companies form a steadily growing segment. As OEMs outsource production for cost savings, faster scalability, and access to specialized expertise, contract manufacturers are becoming important buyers of membranes, pads, and other consumables. This trend is especially strong in Asia-Pacific, where favorable labor costs and supportive manufacturing ecosystems encourage global companies to partner with local producers, further boosting demand for components from this segment.
"The Asia Pacific is the fastest-growing region of the lateral flow assay components market by region."
The global lateral flow assay components market is segmented into five segments, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is expected to achieve the highest CAGR in the lateral flow assay components market during the forecast period, driven by rapid healthcare expansion, strong economic growth, and increasing investments from both domestic and international players. Key contributors to this growth include high-growth countries such as China, India, Japan, South Korea, Taiwan, Australia, and Singapore. Factors like rising healthcare expenditure, an aging population, longer life expectancy, and the increasing demand for point-of-care and home-based testing are boosting demand for membranes, conjugate pads, gold nanoparticles, and other LFA components. China and India remain the most influential markets due to their expanding healthcare infrastructure, rising incomes, and government focus on diagnostics. India's increased health budget for FY 2023-24 underscores this commitment. Meanwhile, Southeast Asian economies like Vietnam, Indonesia, and the Philippines are emerging as new growth centers, driven by strong GDP growth, increased manufacturing capacity, and foreign investment. Despite these growth drivers, challenges such as limited awareness of near-patient testing benefits, inadequate reimbursement structures, and infrastructural gaps in rural and remote areas pose barriers to full adoption. Nevertheless, the presence of competitive local manufacturers such as Advanced Microdevices Ltd. (India), J. Mitra & Co. (India), Nupore Filtration (China), and Equinox (China), alongside multinational suppliers, is strengthening the region's LFA component ecosystem and maintaining its position as the fastest-growing regional market.
Note 1: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.
Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.
Note 3: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
The major players operating in the lateral flow assay components market are Danaher Corporation (US), Sartorius AG (Germany), Merck KGaA (Germany), Ahlstrom (Finland), Advanced Microdevices Pvt. Ltd. (India), DCN Diagnostics (US), Fortis Life Sciences, LLC. (US), Cobetter (China), Axiva Sichem Pvt. Ltd. (India), and Nupore Filtration Systems (India).
Research Coverage
This report examines the lateral flow assay components market based on product, application, technique, end user, and region. It also evaluates factors such as drivers, restraints, opportunities, and challenges impacting market growth, and provides details about the competitive landscape of market leaders. Additionally, the report analyzes micro-markets concerning their individual growth trends. It forecasts the revenue of market segments across five major regions and their respective countries regions).
Reasons to Buy the Report
The report will help both established firms and smaller entrants assess the market, which can assist them in gaining a larger market share. Companies purchasing the report can utilize one or a combination of the strategies listed below to strengthen their market position presence.